ES555289A0 - Procedimiento para preparar una composicion efervescente de rapida disolucion de un agente terapeutico - Google Patents
Procedimiento para preparar una composicion efervescente de rapida disolucion de un agente terapeuticoInfo
- Publication number
- ES555289A0 ES555289A0 ES555289A ES555289A ES555289A0 ES 555289 A0 ES555289 A0 ES 555289A0 ES 555289 A ES555289 A ES 555289A ES 555289 A ES555289 A ES 555289A ES 555289 A0 ES555289 A0 ES 555289A0
- Authority
- ES
- Spain
- Prior art keywords
- preparing
- procedure
- therapeutic agent
- rapid dissolution
- effervescent composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74014485A | 1985-05-31 | 1985-05-31 | |
US77593185A | 1985-08-30 | 1985-08-30 | |
US06/819,093 US4687662A (en) | 1985-08-30 | 1986-01-15 | Therapeutic effervescent composition |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8707109A1 ES8707109A1 (es) | 1987-07-16 |
ES555289A0 true ES555289A0 (es) | 1987-07-16 |
Family
ID=27419258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES555289A Expired ES8707109A1 (es) | 1985-05-31 | 1986-05-23 | Procedimiento para preparar una composicion efervescente de rapida disolucion de un agente terapeutico |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0203768B2 (es) |
JP (1) | JPH0742226B2 (es) |
AU (1) | AU570360B2 (es) |
CA (1) | CA1272133A (es) |
DE (1) | DE3673073D1 (es) |
DK (1) | DK238886A (es) |
ES (1) | ES8707109A1 (es) |
FI (1) | FI85648C (es) |
IE (1) | IE59106B1 (es) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8528195D0 (en) * | 1985-11-15 | 1985-12-18 | Boots Co Plc | Therapeutic compositions |
CH675537A5 (es) * | 1988-03-25 | 1990-10-15 | Ciba Geigy Ag | |
US5211957A (en) * | 1988-03-25 | 1993-05-18 | Ciba-Geigy Corporation | Solid rapidly disintegrating dosage form |
CH677606A5 (es) * | 1988-07-12 | 1991-06-14 | Aesculapius Pharma Sa | |
GB8820327D0 (en) * | 1988-08-26 | 1988-09-28 | May & Baker Ltd | New compositions of matter |
DE3838431A1 (de) * | 1988-11-12 | 1990-05-17 | Bayer Ag | Ibuprofen-brausezubereitungen |
ES2060736T3 (es) * | 1989-01-12 | 1994-12-01 | Bayer Ag | Composicion antiacida analgesica efervescente con un contenido en sodio reducido. |
DE59006174D1 (de) * | 1989-04-07 | 1994-07-28 | Ciba Geigy Ag | Pestizide Wirkstoffkonzentrate und ihre Herstellung. |
US5262179A (en) * | 1989-09-13 | 1993-11-16 | Nicholas Kiwi Pty Ltd. | Non-effervescent ibuprofen compositions |
GB9027827D0 (en) * | 1990-12-21 | 1991-02-13 | Glaxo Laboratoires | Pharmaceutical compositions |
US5468504A (en) * | 1990-12-21 | 1995-11-21 | Laboratoires Glaxo S.A. | Effervescent pharmaceutical compositions |
EP0574624B1 (en) * | 1992-06-17 | 1997-09-10 | Laboratoires Glaxo Sa | Pharmaceutical compositions |
US5723453A (en) * | 1995-11-13 | 1998-03-03 | Health Corporation | Stabilized, water-soluble aspirin composition |
DE19606151C2 (de) | 1996-02-20 | 1999-05-12 | Losan Pharma Gmbh | Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben |
EP0906753B1 (de) * | 1997-09-16 | 2003-06-04 | Dr. Gergely & Co. | Brausezubereitung und Verfahren zu ihrer Herstellung |
GB2344597A (en) * | 1998-12-08 | 2000-06-14 | Procter & Gamble | Effervescence components |
US6683043B1 (en) | 1998-12-08 | 2004-01-27 | The Procter & Gamble Company | Process for manufacturing effervescence components |
US8778398B2 (en) | 2008-11-04 | 2014-07-15 | Jazz Pharmaceuticals, Inc. | Immediate release formulations and dosage forms of gamma-hydroxybutyrate |
EP2189154A1 (en) * | 2008-11-25 | 2010-05-26 | Gnosis S.p.A. | Effervescent tablets and mouth-soluble granulates of S-adenosyl methionine and process for the preparation thereof |
MX2020011961A (es) | 2010-03-24 | 2022-04-19 | Jazz Pharmaceuticals Inc | Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas. |
CN102946869B (zh) * | 2010-05-04 | 2016-08-03 | 爵士制药有限公司 | γ-羟基丁酸的速释制剂及剂型 |
US8580853B2 (en) | 2011-06-13 | 2013-11-12 | Howard PHYKITT | Analgesic composition and method of making the same |
JP5841433B2 (ja) * | 2012-01-11 | 2016-01-13 | 日東電工株式会社 | 口腔内フィルム状基剤及び製剤 |
EP2809311A1 (en) * | 2012-01-31 | 2014-12-10 | Mahmut Bilgic | Effervescent tablet formulations comprising the combination of voglibose and metformin |
WO2013115745A1 (en) * | 2012-01-31 | 2013-08-08 | Mahmut Bilgic | A process for production of pharmaceutical (effervescent) composition comprising alpha - glucosidase inhibitor (e.g. vogliobose and metformin) |
WO2016024928A1 (en) * | 2014-08-14 | 2016-02-18 | Bi̇ofarma İlaç Sanayi̇ Ve Ti̇caret A.Ş. | Taste masked paracetamol formulations |
US20170252295A1 (en) | 2014-09-17 | 2017-09-07 | Steerlife India Private Limited | Effervescent composition and method of making it |
US10398662B1 (en) | 2015-02-18 | 2019-09-03 | Jazz Pharma Ireland Limited | GHB formulation and method for its manufacture |
WO2017098481A1 (en) | 2015-12-12 | 2017-06-15 | Steerlife India Private Limited | Effervescent compositions of metformin and processes for preparation thereof |
US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11986451B1 (en) | 2016-07-22 | 2024-05-21 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
UY37341A (es) | 2016-07-22 | 2017-11-30 | Flamel Ireland Ltd | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada |
US20180263936A1 (en) | 2017-03-17 | 2018-09-20 | Jazz Pharmaceuticals Ireland Limited | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
US11202756B2 (en) * | 2018-04-18 | 2021-12-21 | Shilpa Medicare Limited | Oral disintegrating film compositions of paracetamol |
CN113395960A (zh) | 2018-11-19 | 2021-09-14 | 爵士制药爱尔兰有限公司 | 抗酒精药物制剂 |
JP2022522270A (ja) | 2019-03-01 | 2022-04-15 | フラメル アイルランド リミテッド | 食事摂取状態における改善された薬物動態を有するガンマ-ヒドロキシ酪酸塩組成物 |
US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE759520A (fr) * | 1969-11-28 | 1971-04-30 | Aspro Nicholas Ltd | Compositions d'aspirine |
FR2092893B1 (es) * | 1970-06-29 | 1973-07-13 | Bru Jean | |
FR2132521A1 (en) * | 1971-04-06 | 1972-11-24 | Sofrader Sa | Effervescent tablets prdn - by controlled drying in effervescent granule formation |
US4196127A (en) * | 1978-06-01 | 1980-04-01 | Research Corporation | Anthracyclines |
DE2842822C3 (de) * | 1978-09-30 | 1982-05-19 | Merz + Co GmbH & Co, 6000 Frankfurt | Arzneistoffzubereitungen schwerlöslicher Arzneistoffe in Form von Brausegranulaten |
AU528310B2 (en) * | 1978-11-16 | 1983-04-21 | Beecham Group Plc | Composition of paracetamol and metoclopramide |
-
1986
- 1986-05-06 IE IE120586A patent/IE59106B1/en not_active IP Right Cessation
- 1986-05-19 FI FI862094A patent/FI85648C/fi not_active IP Right Cessation
- 1986-05-20 DE DE8686303814T patent/DE3673073D1/de not_active Expired - Lifetime
- 1986-05-20 EP EP19860303814 patent/EP0203768B2/en not_active Expired - Lifetime
- 1986-05-21 AU AU57644/86A patent/AU570360B2/en not_active Expired
- 1986-05-22 JP JP61116291A patent/JPH0742226B2/ja not_active Expired - Fee Related
- 1986-05-22 DK DK238886A patent/DK238886A/da not_active Application Discontinuation
- 1986-05-23 CA CA000509845A patent/CA1272133A/en not_active Expired - Fee Related
- 1986-05-23 ES ES555289A patent/ES8707109A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
EP0203768A2 (en) | 1986-12-03 |
EP0203768B2 (en) | 1993-05-26 |
DE3673073D1 (de) | 1990-09-06 |
DK238886D0 (da) | 1986-05-22 |
AU570360B2 (en) | 1988-03-10 |
IE861205L (en) | 1986-11-30 |
EP0203768A3 (en) | 1988-02-10 |
FI85648C (fi) | 1992-05-25 |
FI862094A (fi) | 1986-12-01 |
IE59106B1 (en) | 1994-01-12 |
FI85648B (fi) | 1992-02-14 |
ES8707109A1 (es) | 1987-07-16 |
JPS6212715A (ja) | 1987-01-21 |
AU5764486A (en) | 1986-12-04 |
FI862094A0 (fi) | 1986-05-19 |
CA1272133A (en) | 1990-07-31 |
DK238886A (da) | 1986-12-01 |
JPH0742226B2 (ja) | 1995-05-10 |
EP0203768B1 (en) | 1990-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES555289A0 (es) | Procedimiento para preparar una composicion efervescente de rapida disolucion de un agente terapeutico | |
MX160316A (es) | Procedimiento para preparar una composicion terapeutica de accion prolongada a base de hidroxipropilmetilcelulosa | |
ES549326A0 (es) | Un procedimiento para encapsular un agente blanqueante halo-genado | |
AR240874A1 (es) | Un metodo para preparacion de una composicion que contiene un agente biologicamente activo de leberacion prolongada | |
AR229354A1 (es) | Procedimiento para preparar una formulacion estabilizada de ivermectina en agua | |
IT8653757V0 (it) | Dispositivo erogatore per la sommi nistrazione in modo istantaneo e continuato di un agente benefico | |
EP0357665A4 (en) | Rapidly dissoluble medicinal dosage unit and method of manufacture | |
CS253187A2 (en) | Continuous method of pharmaceutical mixtures tableting | |
DK589086A (da) | Farmaceutisk sustained release praeparat indeholdende dextromethorphansamt dets fremstilling og anvendelse | |
PH24517A (en) | Di-t-butyl compounds,their pharmaceutical formulations and a method of use thereof | |
ES554346A0 (es) | Procedimiento de combinacion en solucion de un agente de curado quinoide para composiciones obturadoras | |
NO171344C (no) | Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator | |
ES555353A0 (es) | Un procedimiento para preparar una formulacion farmaceutica liofilizada de activador de plasminogeno de tejidro (t-pa) | |
MX160317A (es) | Procedimiento para preparar una composicion terapeutica de accion prolongada a base de hidroxipropilmetilcelulosa | |
ES539500A0 (es) | Procedimiento para preparar una formulacion liquida farma- ceutica de formas de dosificacion de liberacion controlada doblemente revestidas | |
ZA882771B (en) | Rapidly dissoluble medicinal dosage unit and method of manufacture | |
BR8505469A (pt) | Agente pressurizado de fornecimento para higiene oral | |
KR890701094A (ko) | 활성성분의 피부조직 전이흡수를 보장하는 약제학적 제제형 및 그 조제방법 | |
EP0212501A3 (en) | Therapeutic agent for treating hematopoietic diseases | |
IT8448983A0 (it) | Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina | |
GB8629568D0 (en) | Therapeutic agent | |
IT8347795A0 (it) | Agente fibrinoliticamente attivo emetodo per la sua preparazione | |
ZM10686A1 (en) | New orth-anisamides process for their preparation and their therapeutic application | |
IT8422954A1 (it) | Procedimento per ottenere una formulazione a rilascio controllato di componenti solubilt in acqua. | |
PL252062A1 (en) | Method of obtaining pharmaceutical preparations exibiting prolonged therapeutic action |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 20060527 |